Gross margins decline — Yair Malca stated, "GAAP and non-GAAP gross margins in Q3 were 78%, down from 82% reported in Q3 2024," citing the anticipated impact of tariffs as a direct driver. Reduced ...

Earnings call InMode reported Q3 2025 revenue of $93.2M, down 28.4% YoY due to a tough comp with $31.9M in prior-year pre-orders. Consumables grew 26% YoY, and international sales rose 10% YoY. Gross ...

IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of ...

On Tuesday, 12 August 2025, InMode Ltd (NASDAQ:INMD) presented its strategic outlook at Canaccord Genuity’s 45th Annual Growth Conference. CFO Yair Malca acknowledged that while the company’s Q2 ...

InMode Ltd. beats earnings expectations. Reported EPS is $0.47, expectations were $0.43. Operator: Good day, and welcome to InMode’s Second Quarter 2025 Earnings Results Conference Call. [Operator ...

Starting with total revenue, InMode generated $86.4 million in the second quarter of 2024. However, pro forma revenue was $102.6 million, which includes pre-orders of new platforms not yet delivered.

InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...

InMode Define uses a combination of three technologies to improve the look of the skin. Combining radiofrequency with other techniques, treatments trigger collagen production and make your skin look ...

InMode shares experienced a significant drop of 20% in one trading day, but the decline is seen as excessively harsh. InMode's unique product line bridges the gap between surgical procedures and ...

Shares of InMode (NASDAQ: INMD), a medical technology company focused on the aesthetics industry, recently reached a new 52-week high in anticipation of the second-quarter earnings report the company ...